Indefinite Delivery Contract SPE2DU25D1215

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp to provide pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, with a base period through December 2026 and three 30-month option periods, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement. The IDC encompasses a comprehensive range of...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The $999,999,999 IDC has a 30-month base period and three 30-month option periods, totaling a potential 10-year period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical and medical supply products to support military healthcare programs globally. The $999,999,999 IDC has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion across multiple regional awards. The contract is...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. This single-award IDC has a period of performance through December 2036 and will serve as a primary vehicle for the DLA to procure specialty medications, brand-name and generic drugs, vaccines, syringes,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC will serve as the primary vehicle for the DLA to procure brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and other critical medical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, which runs through December 2036, will serve as the primary vehicle for procuring specialty medications, brand-name and generic drugs, vaccines,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. This single-award IDC has a 30-month base period and three 30-month option periods, for a total period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for the DLA Troop Support's Pharmaceutical Prime...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period with three 30-month option periods, for a total potential period of performance through December 2036. The IDC aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999.00, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet, through the Pharmaceutical Prime Vendor Global Program...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The IDC covers a 30-month base period with three 30-month option periods, totaling an estimated $30.3 billion in value across multiple regional contracts. This IDC, known as the Pharmaceutical Prime Vendor Global Program Generation...

The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 IDC has a period of performance through November 2026 and covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This IDC is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The procurement is an unrestricted, fully competitive acquisition with a total estimated value of $30.3 billion over the base and option periods. Awards will be made on a regional basis, with at least three different contractors selected to ensure diversification and resiliency of the DoD's access to vital pharmaceuticals during contingencies or natural disasters.

Generated 7/1/25, 9:41 AM